Podcasts

Episode 9 features the entire Pharm Exec editorial team, discussing each selection of this year's Brand of the Year and why we chose them.

Episode 8 highlights Tim Sullivan, CFO of Apellis Pharmaceuticals, who provides listeners an inside look at what it takes to be the CFO of a development-stage biotch company, and what business skills someone needs to succeed in that type of position.

On episode 7, Pharm Exec editors discuss key takeaways from a variety of industry conferences that took place across the globe.

On episode 6, Michelle and Christen talk to Lara Sullivan, founder and president of SpringWorks Therapeutics, about the differences in working for legacy pharma vs. small biotech start-ups.

Michelle and Christen talk with William Soliman about Accreditation Council for Medical Affairs (ACMA).

In this episode, Michelle and Christen talk to Editor-in-Chief Lisa Henderson and European Editor Julian Upton about outcomes-based contracting from the March issue.

In this episode, Christen and Michelle talk to Devyn Smith, chief strategy officer and head of operations for Sigilon Therapeutics, on the topic of pharma's reputation, both in the US and Europe.

In this episode, Michelle and Christen speak with Marc O'Connor, chief operating officer at Curant Health, and Pharm Exec's Editor-in-Chief, Lisa Henderson with insights on the JPMorgan Healthcare Conference that took place at the beginning of January.

In this podcast, Pharmaceutical Executive editors, Christen Harm and Michelle Maskaly, discuss the 2018 pharma trends, specifically biosimilars and eEnablement, and takeaways from the 2017 Veeva European Commercial Summit.